Young Investigators Award
The Macrae Group LLC is sponsoring Young Investigator Awards which assist academic investigators (less than 35 years of age) requiring financial support in order to present new data at each of our meetings.
-
February
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|
| | | 1 | 2 | 3 | 4 |
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | | | |
|
- Info
Program
1st International Congress on Exacerbations of Airway Disease (ICEAD)
San Juan, Puerto Rico
October 4 - 7, 2007
7:30-8:30 am
|
BREAKFAST
|
Session I: Epidemiology
|
8:30-8:50 am
|
Definitions & Epidemiology of COPD Exacerbations
Roberto Rodriguez Roisin, University of Barcelona, Spain |
| 8:50-9:00 am |
Discussion |
9:00-9:20 am
|
Morbidity, Mortality and Health
Care Costs of COPD Exacerbations
Donald Sin, University of British Columbia, Vancouver, Canada (invited) |
| 9:20-9:30 am |
Discussion |
9:30-9:50 am
|
Definitions & Epidemiology of Asthma Exacerbations
Malcolm Sears, McMaster University, Hamilton, Ontario, Canada |
| 9:50-10:00 am |
Discussion |
10:00-10:20 am
|
Morbidity, Mortality and Health Care Costs of Asthma Exacerbations
Ian Town, University of Canterbury, Christchurch, New Zealand |
| 10:20-10:30 am |
Discussion |
| 10:30-11:00 am |
Late Breaker Abstracts (2x15 min) |
| 11:00-11:30 am |
COFFEE BREAK
|
Session II: Etiology
|
11:30-11:50 am
|
Etiology of Asthma Exacerbations
Seb Johnston, Imperial College, London, UK |
| 11:50-12:00 pm |
Discussion |
12:00-12:20 pm
|
Etiology of COPD Exacerbations
Sanjay Sethi, University at Buffalo, SUNY, Buffalo, New York, USA |
| 12:20-12:30 pm |
Discussion |
| 12:30-1:00 pm |
Late Breaker Abstracts (2x15 min) |
| 1:00-3:30 pm |
MID-DAY BREAK
|
Session III: Susceptibility to Exacerbation
|
3:30-3:50 pm
|
Asthma
Fernando Martinez, University of Arizona Tucson, Arizona (invited) |
| 3:50-4:00 pm |
Discussion |
4:00-4:20 pm
|
COPD
Wisia Wedzicha, University College London & Royal Free Hospital,
London, UK |
| 4:20-4:30 pm |
Discussion |
| 4:30-5:00 pm |
Late Breaker Abstracts (2x15 min) |
5:30-7:00 pm
|
Poster Session
Wine & Cheese Reception
|
|
|
| 7:30-8:30 am |
BREAKFAST
|
Session IV: Pathogenesis
|
8:30-8:50 am
|
Physiology of Exacerbations in COPD and Asthma
Dennis O'Donnell, Kingston, ON, Canada |
8:50-9:00 am
|
Discussion |
9:00-9:20 am
|
Cellular Mechanisms of COPD Exacerbations
Marina Saetta, University of Padova, Italy |
| 9:20-9:30 am |
Discussion |
9:30-9:50 am
|
Molecular Mechanisms of COPD Exacerbations
Bill MacNee, University of Edinburgh, UK |
| 9:50-10:00 am |
Discussion |
10:00-10:20 am
|
Cellular mechanisms of asthma exacerbations
Bill Busse, University of Wisconsin Madison, Wisconson, USA |
| 10:20-10:30 am |
Discussion |
10:30-10:50 am
|
Molecular Mechanisms of Asthma Exacerbations
Alberto Papi, University of Ferrara, Italy (invited) |
| 10:50-11:00 am |
Discussion |
| 11:00-11:30 am |
COFFEE BREAK |
| 11:30-12:00 pm |
Late Breaker Abstracts (2x15 min)
|
Session V: Current Treatment
|
12:00-12:20 pm
|
How Good is Current Therapy in Treatment and Prevention of
Asthma Exacerbations?
Paul O'Byrne, McMaster University, Hamilton, Ontario, Canada |
| 12:20-12:30 pm |
Discussion |
12:30-12:50 pm
|
How Good is Current Therapy in Treatment and Prevention of
COPD Exacerbations?
Jorgen Vestbo, Hvidovre Hospital, Denmark |
| 12:50-1:00 pm |
Discussion |
| 1:00-1:30 pm |
Late Breaker Abstracts (2x15 min) |
| 1:30-4:00 pm |
MID-DAY BREAK |
|
|
Session VI: Clinical Trial Design and Outcomes
|
4:00-4:20 pm
|
Issues in Clinical Trial Strategies in COPD Exacerbations
Stephen Rennard ΠUniversity of Nebraska Medical Center, Omaha, Nebraska, USA |
| 4:20-4:30 pm |
Discussion |
4:30-4:50 pm
|
Issues in Clinical Trial Strategies in Asthma Exacerbations
Dirkje Postma, University Hospital Groningen, The Netherlands (invited) |
| 4:50-5:00 pm |
Discussion |
| 5:00-5:30 pm |
Late Breaker Abstracts (2x15 min)
|
|
|
| 7:30-8:30 am |
BREAKFAST
|
Session VII: Future Treatments
|
8:30-8:50 am
|
Non-invasive Monitoring - Can Exacerbations be Prevented?
Robin Taylor, Dunedin New Zealand |
| 8:50-9:00 am |
Discussion |
9:00-9:20 am
|
Future Therapies for Asthma Exacerbations
Stephen Holgate, University of Southampton School of Medicine,
Hampshire, UK (invited) |
| 9:20-9:30 am |
Discussion |
9:30-9:50 am
|
Future Therapies for COPD Exacerbations
Peter Barnes, National Heart and Lung Institute, London UK |
| 9:50-10:00 am |
Discussion |
| 10:00-10:30 am |
COFFEE BREAK |
| 10:30-11:00 am |
Late Breaker Abstracts (2x15 min) |
11:00-12:00 pm
|
Future Directions Panel Discussion
Chair: Leonardo Fabbri, University of Modena, Italy |
|
